Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
RCUS | Arcus Biosciences, Inc. | Director | $444K | Jun 6, 2024 | ||
SLRN | ACELYRIN, Inc. | Director | $109K | Jun 7, 2024 | ||
ADVM | Adverum Biotechnologies, Inc. | Director | Jun 17, 2024 | |||
ALMS | ALUMIS INC. | Director | Jun 27, 2024 | |||
CMRX | CHIMERIX INC | Director | Jun 9, 2023 | |||
ROIV | Roivant Sciences Ltd. | Director | Oct 1, 2021 | |||
TPTX | Turning Point Therapeutics, Inc. | Director | Aug 17, 2022 | |||
TSBX | Turnstone Biologics Corp. | Director | Jul 20, 2023 | |||
XENE | Xenon Pharmaceuticals Inc. | Director | Jun 5, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|